Caris Life SciencesCAI
Close of Friday, October 23, 2026 · Caris Life Sciences is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$32.00
vs its Pivot
+49.6%
OnlyAlpha Score
57
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot. ▲ closed at least 1% above the Pivot (in) · ▼ closed below it (out). Hover or drag across the chart for any day.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -0.8% | +18.6% | +6.5% | — | — |
No dividend in the last 12 months.
Who runs and owns it
Run by David Dean Halbert (founder, chair & CEO), one of the Forbes billionaires.
In these funds
IBB · 0.26%IYH · 0.06%
Big investors that own it (latest 13F)
| OrbiMed Carl Gordon | 0.9% of holdings |
| Duquesne Family Office Stanley Druckenmiller | 0.8% of holdings |
| Coatue Philippe Laffont | 0.4% of holdings |
Healthcare · Medical devices
Get CAI in your free daily emailAfter every close: whether CAI is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track CAI free → Full Stock check
Track CAI free → Full Stock check